Skip to main content

UBS Group AG

Position in EDIT — Editas Medicine, Inc.

CIK 1610520 ZURICH, V8

Position in EDIT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$972,571
-$686,579 QoQ
Shares Held
393,754
-51.3% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.18287560253356.ToString("F0")% Shared 0.ToString("F0")% None 1.8171243974664384.ToString("F0")%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. EDIT ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EDIT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $972,571 393,754
2025-12-31 $1,659,150 809,342
2025-09-30 $1,465,706 422,394
2025-06-30 $1,386,789 630,359
2025-03-31 $1,410,991 1,216,374
2024-12-31 $1,416,150 1,115,080
2024-09-30 $1,400,173 410,609
2024-06-30 $1,597,703 342,121
2024-03-31 $4,422,059 595,965
2023-12-31 $1,458,809 144,009
2023-09-30 $848,967 108,842
2023-06-30 $1,527,824 185,641
2023-03-31 $3,609,513 497,864
2022-12-31 $3,610,213 407,014
2022-09-30 $1,088,147 88,901
2022-06-30 $3,322,619 280,864
2022-03-31 $4,594,908 241,583
2021-12-31 $3,755,098 141,435
2021-09-30 $3,927,082 95,596
2021-06-30 $5,688,978 100,441
2021-03-31 $2,407,902 57,331
2020-12-31 $6,179,143 88,135
2020-09-30 $1,748,502 62,313
2020-06-30 $2,047,468 69,218
2020-03-31 $1,122,694 56,616